首页 | 本学科首页   官方微博 | 高级检索  
     

子宫内膜癌PCNA表达和雌孕激素受体的研究
引用本文:陈永平,沈明,陈晨,傅春燕. 子宫内膜癌PCNA表达和雌孕激素受体的研究[J]. 中南大学学报(医学版), 2001, 26(2): 123-125
作者姓名:陈永平  沈明  陈晨  傅春燕
作者单位:中南大学湘雅医学院病理学教研室,;中南大学湘雅医学院病理学教研室,;中南大学湘雅医学院病理学教研室,;中南大学湘雅医学院病理学教研室,
摘    要:目的 :探讨子宫内膜癌 (endometrialcarcinoma ,EMC)增殖活性以及雌、孕激素受体的表达与临床病理特性、预后的关系。方法 :采用免疫组织化学方法检测 74例子宫内膜癌增殖细胞核抗原 (proliferatingcellnucleusantigen ,PCNA)、雌激素受体 (estrogenreceptor ,ER)、孕激素受体 (progesteronereceptor ,PR)含量。结果 :PCNA在对照组和EMC中的阳性率分别为 30 .0 %和 82 .4% ,差异有显著性 (P <0 .0 1) ;在不同分化程度的EMC中PCNA阳性表达率差异无显著性 ,但PCNA阳性指数 (PI)评分 ,WD明显低于MD ,LD ,差异有显著性 (P <0 .0 0 1) ,且与EMC分化程度呈负相关(r = 0 .5 2 ,P <0 .0 1) ;PCNAPI评分与EMC临床期别之间呈正相关 (r =0 .5 5 ,P <0 .0 1)。EMC中ER ,PR阳性例数分别为 49例 (6 6 .2 % )和 5 6例 (75 .7% ) ,PCNA表达与ER ,PR受体之间呈负相关 ,r值分别为 - 0 .42 (P <0 .0 5 )和 - 0 .5 1(P <0 .0 5 )。结论 :ER和PR阳性、PCNAPI评分较低的子宫内膜癌 ,肿瘤细胞异型性小 ;反之 ,表现为侵犯邻近组织、扩散、转移等恶性生物学行为。ER ,PR和PCNA表达之间有明显互补性。PCNA表达结合ER ,PR检测具有方法简单、组织无需特殊处理等特点 ,适于对常规病理切片作回顾性研究 ,对鉴别肿瘤性质、预测预后均有

关 键 词:子宫内膜肿瘤  增殖细胞核抗原*  受体  雌激素  孕激素  免疫组织化学
文章编号:1000-5625(2001)02-0123-03
修稿时间:2000-12-25

Study on expression of PCNA and estrogen, progesterone receptors in endometrial carcinoma
CHEN Yong ping,SHEN Ming,CHEN Chen,et al. Study on expression of PCNA and estrogen, progesterone receptors in endometrial carcinoma[J]. Journal of Central South University. Medical sciences, 2001, 26(2): 123-125
Authors:CHEN Yong ping  SHEN Ming  CHEN Chen  et al
Affiliation:(Department of Pathology, Xiangya Medical College,Central South University, Changsha 410078, China)
Abstract:Objective To investigate the proliferating ability of tumor cells in 74 cases with endometrial carcinoma (EMC), as well as define the correlation between clinical pathology, prognostic features and estrogen receptor (ER), progesterone receptor (PR). Methods Proliferating cell nucleus antigen (PCNA) and ER/PR content were examined using immunohistochemical assay. Results PCNA was expressed in both benign hyperplasia and EMC, but positive rate in the latter was significantly higher than that in the former (82.4% vs 30.0%)(P<0.01). EMC well differentiated had lower proliferating index (PI) score than those moderately and poorly differentiated(P<0.001), and the PI score was negatively related to the grade of differentiation(r=-0.52, P<0.01). PI score in early cases (Ⅰ/Ⅱ) was significantly lower than that in advanced ones(Ⅲ/Ⅳ) (P<0.05), and the PI score was positively related to the clinical stages (r=0.55, P<0.01). Positive rates of ER, PR were 66.2% (49/74) and 75.7%(56/74) respectively, expression of PCNA was negatively related with ER and PR(r=-0.42,-0.51,respectively,P<0.05). Conclusions EMC cells with poorer differentiation or in more advanced stages have faster proliferating ability and aggressive biological behavior. Expression of PCNA combined with detection of ER/PR not only apts to retrospective study, but also has some prognostic value.
Keywords:endometrial neoplasms  proliferating cell nucleus antigen *  receptor   estrogen  receptor   progesterone  immunohistochemistry
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《中南大学学报(医学版)》浏览原始摘要信息
点击此处可从《中南大学学报(医学版)》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号